Cardiome Pharma Corp.

Clinic Roundup.
BIOWORLD Today; 12/21/2009; 633 words; o Cardiome Pharma Corp., of Vancouver, British Columbia, said its Phase III European comparator...with no vernakalant-related deaths of cases of Torsades de Pointes. Cardiome partnered European rights to I.V. vernakalant to Whitehouse Station...

Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans.
PR Newswire; 12/21/2009; 1821 words; ...PRNewswire-FirstCall/ -- Cardiome Pharma Corp. today announced that it has...dispositions will occur under the plan. Cardiome recognizes that its directors...whether to effect transactions in Cardiome's securities. Such personal...

Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study.
PR Newswire; 12/17/2009; 1198 words; ...VANCOUVER, Dec. 17 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. today announced that the recently-completed...12-lead ECGs, and laboratory tests. About Cardiome Pharma Corp. Cardiome Pharma Corp. is a product-focused drug development...

Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care.
Heart Disease Weekly; 12/6/2009; 1651 words; ...The company has ongoing cardiovascular collaborations with Actelion Pharmaceuticals, Arena Pharmaceuticals, Cardiome Pharma Corp., Galapagos NV, NicOx, Mochida Pharmaceutical Co., Ltd., Millennium, PeriCor Therapeutics, Inc., Portola...

Cardiome to Release Third Quarter Results.(Financial report)
Biotech Week; 11/25/2009; 594 words; Cardiome Pharma Corp. (NASDAQ: CRME)(NASDAQ...to discuss the results (see also Cardiome Pharma Corp.). To access the conference call...to access the replay. Keywords: Cardiome Pharma Corp., Cardiome Pharma Corporation...